Abstract
Nitric oxide (NO) is a diffusible gas with diverse roles in human physiology and disease. Significant progress in the understanding of its biological effects has taken place in recent years. This has led to a better understanding of the pathobiology of pulmonary hypertension (PH) and the development of new therapies. This article provides an overview of the NO physiology and its role in the pathobiology of lung diseases, particularly PH. We also discuss current and emerging specific treatments that target NO signaling pathways in PH.
Funding Information
  • National Center for Research Resources
  • National Institutes of Health (HL081064, HL107147, HL095181, RR026231)
  • Ohio Department of Development
  • American Heart Association (0826095H)

This publication has 173 references indexed in Scilit: